Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab

NCT01784900 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Patients With Gastric Peritoneal Carcinomatosis

Interventions

DRUG: Catumaxomab 100µg
DRUG: Catumaxomab 140µg

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris